Table 1 Study characteristics of included studie
Citation (First author et al.) | Year | Location | No. of participants in meta-analysis | Gender/age (years) | Health condition | Dose (IU/d) | Duration (week) |
|---|---|---|---|---|---|---|---|
Akbari et al. | 2017 | Iran | 371 | Women /NR | GDM | NR | 7.5 |
Ojo et al. | 2019 | UK | 359 | Women /30 | GDM | 2774 | 8.5 |
Guo et al. | 2020 | China | 730 | Women /31 | PCOS | 545.5 | 12 |
Rezaei et al. | 2021 | Iran | 686 | Both /NR | NAFLD | 21000 | 15.5 |
Sarathy et al. | 2014 | Iran | 131 | Both /45 | dialysis patients | NR | 8 |
Tabrizi et al. | 2017 | Iran | 332 | Both /46 | NAFLD | 7000 | 12 |
Zou (a) et al. Zou (b) et al. | 2021 | China | 639 538 | Both/55 Both/60 | Diabetes Prediabetes | 2700 1500 | 12.5 25 |
Wei et al. | 2020 | China | 468 | Both /46 | NAFLD | 10000 | 20 |
Wang et al. | 2021 | China | 389 | Women /26 | PCOS | 5000 | 13 |
Wang et al. | 2019 | China | 230 | Both /51 | DN | 12 | 12 |
Zhang et al. | 2021 | China | 1486 | Both /50 | Prediabetes | 5483 | 47 |
Wu et al. | 2017 | China | 1496 | Both /56 | TD2M | 1970 | 19 |
Elamin et al. | 2011 | USA | 2081 | Both /NR | Elderly people with different diseases | NR | NR |
Sahebi (a) et al. Sahebi (b) et al. | 2018 | Iran | NR | Women /NR | GDM T2DM | NR | NR |
Tang et al. | 2018 | USA | 5509 | Both /NR | Diabetic Adults | NR | NR |
Mirhosseini et al. | 2018 | Canada | 3062 | Both /49 | Prediabetics | 4030 | NR |
Milajerdi et al. | 2019 | Iran | 214 | Both /50 | CKD | 2683 | 8 |
Li et al. | 2018 | China | 2104 | Both /56 | T2DM | 4991 | 18 |
Lee et al. | 2017 | USA | 2295 | Both/54 | T2DM | 3410 | 40 |
Łagowska et al. | 2018 | Poland | 458 | Women/26 | PCOS | 4614 | 16 |
Krul-Poel et al. | 2017 | Netherlands | 1180 | Both /NR | T2DM | 4047 | 24 |
Wang et al. | 2020 | China | 717 | Women /26 | GDM | 1884 | 7 |
Jamka et al. | 2015 | Poland | 590 | Both /NR | Overweight/obese | 3047 | 20 |
Jahanjoo et al. | 2018 | Iran | 223 | Both/30 | GDM | 2976 | 10 |
He et al. | 2018 | China | NR | Both/30 | Diabetics | NR | NR |
Emadzadeh et al. | 2020 | Iran | 722 | Both/46 | Different diseases | 4637 | 17 |
Gasparri et al. | 2019 | Italy | 339 | Both /53 | Different diseases (GDM & T2DM & MetS) | 875 | 12 |
Mirhosseini (a) et al. Mirhosseini (b) et al. | 2017 | Canada | 330 1331 | Both /51 Both /48 | Obese diabetic Non-obese diabetic | 4243 3385 | 32 13 |
Ostadmohammadi et al. | 2019 | Iran | 630 | Both /NR | CVD | NR | NR |
Guo et al. | 2020 | China | 413 | Both /45 | NAFLD | 2878 | 23 |
Pramono et al. | 2020 | Netherlands | 1220 | Both /NR | Diabetes | 4600 | 15 |
Seida (a) et al. Seida (b) et al. Seida (c) et al. | 2014 | Boston | 742 309 471 | Both /51 Both /55 Both /55 | Normal glucose tolerance Prediabetes Established T2DM | 4920 6238 3437 | 42 26 17 |
Hu (a) et al. Hu (b) et al. | 2019 | China | 375 1059 | Both /NR | T2DM | 3782 5030 | 29 (long term) 14 (short term) |
Poolsup et al. | 2015 | Thailand | 537 | Both /53 | prediabetes | 6600 | 40 |
MIAO et al. | 2020 | China | 278 | Both /NR | PCOS | NR | NR |
Manousopoulou et al. | 2015 | UK | 787 | Both /40 | Obesity | 3095 | 26 |
Gallo et al. | 2019 | NR | 366 | Women /29 | Pregnancy | 3413 | 9 |